Drug · BCR-ABL TKI · BCR-ABL TKI · Verified drug
Ponatinib (Iclusig) structure · mechanism
Ponatinib (Iclusig) 2D structure
- Role
- Drug
- Mechanism class
- BCR-ABL TKI
- Parent scaffold
- Phenylaminopyrimidine kinase core
- Structure source
- Catalog seed
Hand-written analysis
Mechanism
포나티닙은 BCR-ABL T315I를 겨냥하는 3세대 TKI입니다. 삼중결합이 gatekeeper를 우회합니다. 동맥폐쇄 위험이 용량과 함께 강조됩니다.
Medicinal chemistry
이미다조피리다진-아세틸렌 골격입니다. 이마티닙 type II와 결합 모드가 다릅니다.
Indication · context
T315I CML/Ph+ ALL. 1·2세대가 놓친 돌연변이를 이 약이 담당합니다.
SMILES
CN1CCN(CC1)C2=CC=C(C=C2)NC(=O)C3=CC(=C(C=C3)C4=CN=C5C(=N4)C=CC(=N5)C6=CC=CC=C6)C(F)(F)FTags
Related compounds
External IDs · BioMoa
StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.